Total Products under this Category: 175
Last updated: November 12, 2026
Why You Can Trust G2's Software Rankings:
G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.
Calculate drug toxicity and safety endpoints to reduce attrition rates of molecular entities that are unlikely to succeed to nomination as a drug candidate, direct new compound synthesis, and focus animal testing requirements.
Pioneering an approach that combines simulation with machine learning, we map and model how thousands of signaling proteins interact characterizing cellular level cancer behavior and response or resistance to treatment. Our platform enables the simulation of drug-like effects from compounds that may not exist yet, on cells potentially unavailable for lab-based testing, like those of high unmet need cancer patients.
Valinor Discovery uses machine learning to simulate drug performance and support data-driven drug development decisions.
Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.
Variational AI is a pioneering company that leverages generative artificial intelligence to revolutionize drug discovery. Their proprietary platform, Enki™, utilizes advanced machine learning algorithms to generate novel, drug-like small molecules tailored to specific therapeutic targets. By focusing on creating new molecules rather than screening existing ones, Variational AI aims to expedite the development of efficacious, safe, and synthesizable small molecule therapeutics, particularly in the field of oncology.
2D to 3D small molecule conversion. Provides low energy conformers of drug-like molecules. Detects and enforces stereochemistry.
A comprehensive free energy software package for computer-aided drug discovery and molecular design.
Xaira Therapeutics is pioneering the integration of artificial intelligence (AI) into drug discovery and development, aiming to transform the creation of life-changing medicines. By combining advanced AI research, extensive data generation, and robust therapeutic product development, Xaira seeks to make biology more computable and shift drug discovery from an empirical science to a precise engineering discipline. Their approach is built on foundational work by co-founder and Nobel Laureate Dr. David Baker, leveraging AI to design entirely new proteins from scratch, enabling the creation of medicines against molecular targets that have been resistant to other approaches.
Xavo has reimagined how to address the strategic problem in the Biopharma R&D Sample Management realm which is to optimally fulfill changing demand for assays and materials based on available finite lab capacity and material inventory
